Alzheimer disease (AD) is a frequent and devastating neurodegenerative disease in
humans, but still no curative treatment has been developed. Although many explicative …

Alzheimer's disease (AD) is characterized by non-linear, genetic-driven pathophysiological
dynamics with high heterogeneity in biological alterations and disease spatial-temporal …

Alzheimer's disease (AD), the most common form of dementia, is recognized as a
heterogeneous disease with diverse pathophysiologic mechanisms. In this study, we …

Alzheimer's disease (AD) is the most common form of dementia, characterized by
progressive cognitive impairment and neurodegeneration. Extensive clinical and genomic …

Alzheimer's disease (AD) is currently incurable, but there is general agreement that a
minimally invasive blood biomarker for screening in preclinical stages would be crucial for …

Stroke recovery is the next frontier in stroke medicine. While growth in rehabilitation and
recovery research is exponential, a number of barriers hamper our ability to rapidly progress …

While Alzheimer's disease (AD) classical diagnostic criteria rely on clinical data from a
stablished symptomatic disease, newer criteria aim to identify the disease in its earlier …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that slowly destroys
memory and thinking skills, resulting in behavioral changes. It is estimated that nearly 36 …

Introduction Brain cells secrete extracellular microvesicles (EVs) that cross the blood‐brain
barrier. Involved in cell‐to‐cell communication, EVs contain surface markers and a …

Neurodegenerative diseases, such as Alzheimer′ s diseases (AD), are becoming more
prevalent as the population ages. However, the mechanisms that lead to synapse …